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ABSTRACT 
Objective: To evaluate and compare the particle and tableting properties of a new sorbitol (SOR) and anhydrous calcium diphosphate (ACD) 
composite with common excipients used for the preparation of tablets by direct compression such as polyvinylpyrrolidone (Ludipress®), lactose 
(Cellactose 80®) and microcrystalline cellulose (Prosolv SMCC 90®). 
Methods: All materials were tested for lubricant sensitivity, ejection force, and elastic recovery, dilution potential and reworking ability. Further, 
compressibility and compactibility were determined using the Heckel and Leuenberger models, respectively. 
Results: This new excipient offered more benefits in terms of functionality than commercial direct compressive co-processed excipients and 
showed better compressibility than other commercial excipients and its compactibility was ranked third after SOR and Prosolv SMCC 90®. However, 
this composite material was more susceptible to reprocessing than commercial products. Further, it showed a low lubricant sensitivity due to a 
combination of a plastic and brittle behavior. Moreover, the loading capacity of poorly compressible materials such as gemfibrozil was comparable 
to that of commercial direct compression excipients. It also showed the fastest in-vitro dissolution of gemfibrozil, whereas commercial products 
failed to fulfill the US pharmacopoeial requirements. 
Conclusion: This new composite material showed potential for use as a direct compression excipient. 
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INTRODUCTION 
Currently, the solid dosage forms have the largest acceptance 
worldwide and have about 80 % of market share because of their 
versatility, safety, easy handling and good stability to heat and 
moisture as compared to liquid and semi-solid formulations [1].The 
solid dosage forms may be prepared mainly by using technologies 
such as wet granulation, dry granulation or direct compression. 
Direct compression is the simplest and the most inexpensive method 
in which tablets are produced directly from a mixture of the active 
ingredient with suitable excipients. In wet granulation, the active 
ingredient and the excipients are mixed with a wet binder to form an 
aggregate which is then dried and passed through sieves to form 
granules of adequate size for the tableting process [2]. In the dry 
granulation process, the drug and the excipients are mixed and then 
passed through rollers and subsequently screened to obtain 
granules of suitable sizes [3]. 
Among all the above-mentioned processes, direct compression is the 
most desirable because it requires few unit operations, has less 
energy consumption and it provides better stability for moisture, 
oxidation, and temperature sensitive drugs [4]. However, about 80 
% of the tablet formulations are made by wet granulation. This is 
explained by the poor mechanical properties exhibited by most 
drugs [5]. 
An excipient intended for direct compression applications should 
have the following characteristics: excellent compressibility, 
adequate flow, resistance to segregation, rapid disintegration, low 
sensitivity to lubricants, scaling-up feasibility, and good dilution 
potential [6]. The fastest and cheapest way to develop a direct 
compressive excipient is by co-processing. 
Co-processing implies a combination of two or more excipients using 
appropriate technology to obtain a product with improved tableting 
properties as compared to their physical mixture. Therefore, the 
original defects are masked, and the beneficial properties are 
synergized [7]. The most commonly used technologies to obtain co-
processed excipients include spray-drying, agglomeration, hot-melt 
extrusion and co-precipitation [8]. Co-processing minimizes tablet 
breakdown due to lamination and capping, which are in turn, 
attributed to energy built up during the tableting process [6]. 
In a previous study, a novel sorbitol (SOR): anhydrous calcium 
diphosphate(ACD) composites were produced by agglomeration at 
the 95:5; 80:20, 50:50, 20:80 and 6:94 SOR to ACD ratios [ 9]. The 
new agglomerated excipient had better flow, compressibility, and 
compactibility than the physical mixture of SOR and ACD being the 95:5 
ratios the composite that exhibited the best tableting properties [10]. 
Cellactose 80® (α-lactose monohydrate: cellulose powder (75:25), 
Microcellac® (α-lactose monohydrate: microcrystalline cellulose 
(75:25), Prosolv SMCC 90® (microcrystalline cellulose: colloidal 
silicon dioxide (98:2), and Ludipress® (α-Lactose monohydrate: 
Polyvinylpyrrolidone: Crospovidone (93:3.5:3.5) are some of the 
main co-processed excipients currently available on the market. The 
goal of this study is to evaluate the particle and mechanical 
properties of a new agglomerated excipient containing SOR and ACD 
(95:5 ratio), as compared to commercial co-processed materials 
namely Prosolv SMCC 90®, Cellactose 80® and Ludipress® and the 
parent SOR and ACD excipients. 
MATERIALS AND METHODS 
Materials 
Prosolv SMCC 90® (lot 6909030220) was obtained from JRS Pharma 
(Rosenberg, Germany). Magnesium stearate (lot 25654) was 
purchased from Rio Tinto Minerals (Luzenac Val Chisone SA). Sorbitol 
(lot 20,140,405) and calcium diphosphate (lot BCU250711) were 
obtained from Shandong Ruiyang Pharmaceutical Technology 
(Longwood, USA) and Innophos (Cranbury, NJ, USA), respectively. 
Gemfibrozil (lot 241303947010) was obtained from Chemo Lugano 
branch (Lugano, Switzerland). Cellactose 80®(lot 1321) was purchased 
from Meggle (Wasserburg. Germany), Ludipress® (lot 71036447G0), 
Crospovidone (lot 2912588Q0) and sodium lauryl sulfate (lot 
0012730186) were purchased from BASF (Evionnaz, Switzerland). 
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Preparation of the sorbitol and calcium diphosphate (95:5) 
composite 
Approximately, 100 g of ACD and SOR were mixed at a 5:95 ratio and 
wetted with a suitable amount of distilled water (5.5 mL) to form a 
wet mass. This mass was then passed through a # 14 sieve and 
agglomerated in a spheronizer (Model 1LA7 080-6YC60, Medellin, 
Colombia). The agglomeration process was performed for 5 min 
with an angle of 30 degrees and speed of ~100 rpm. The material 
was then dried at 60 °C for 24 h and passed through a 60mesh sieve. 
Particle sizes analysis 
Excipients were fractionated on a Ro-Tap sieve shaker (Model, RX29, 
W. S. Tyler Company, Mentor, OH) using stainless steel 180,150, 125, 
106, 75, 44 and 38 µm size sieves, stacked together in the order 
written (Fisher Scientific Co., Pittsburgh, PA). Approximately, 20 g of 
the sample was shaken for 10 min. The geometric mean diameter, 
dg, was determined from the log-normal distribution plot 
constructed between the sieve mean diameter and cumulative 
percent frequency using the Minitab software (v.16, Minitab, Inc, 
State College, PA). 
Particle properties 
The moisture content was obtained by the gravimetric method 
heating the sample at 105 °C for 10 min in an infrared moisture 
balance (GEHAKA IV 3000). True density was determined using a 
Helium displacement micro pycnometer (AccupycII 13340, 
Micromeritics, USA) with ~2 g of a dry sample. Bulk density was 
determined on 20 g of material, and the tap density was measured 
on a Tap density analyzer (AT2, Quantachrome instruments, USA) 
for 400 taps. Porosity (ε) was calculated as reported previously [11]. 
Flow rate was obtained from ∼20 g of material that passed through a 
glass funnel having a 13 mm diameter orifice, and its weight was 
recorded as a function of time.  
Tablet porosity  
The thickness and diameter of the tablets were measured with an 
electronic digital caliper (Titer, 0.01 mm sensitivity). The thickness of 
the tablets was measured at three different points of the tablet, and the 
average was reported. The compact volume and porosity were 
calculated according to their geometry as reported previously [12]. 
Compressibility analysis 
Compacts of ∼300 mg were made on a single punch tablet machine 
(060804 Compac, Indemec, Itagui, Colombia) coupled with a load 
cell (LCGD-10K, Omega Engineering, Inc., Stamford, CT) at 1 and 30 s 
using a flat-faced 6.5 mm punches and die tooling. Pressures ranged 
from ∼10 MPa to 300 MPa and were measured on a strain gauge 
(LCGD-10K, Omega Engineering, Inc., Stamford, CT). Compacts were 
analyzed immediately after ejected. The natural logarithm of the 
inverse of compact porosity was plotted against compression 
pressure to construct the Heckel plots as reported previously [13]: 
-ln (ε) = kP+A (1) 
Where, A is the intercept obtained by extrapolating the linear region 
to zero pressure. The slope (m) is inversely related to the yield 
material pressure (Py), which is a measure of its plasticity [14]. 
Thus, a low Py (usually values<100 MPa) indicates a high ductile 
deformation mechanism upon compression. Other parameters such 
as Do, Da, and Db, are related to initial powder packing/densification, 
total compact densification and particle rearrangement/ 
fragmentation at the initial compaction stage, respectively [15]. They 
were calculated as described previously [11]. 
Compactibility analysis 
Compacts were made as described under “compressibility analysis”. 
The analysis was performed using a tablet hardness tester (UK 200, 
Vankel, Manasquan, NJ) and the compact tensile strength (MPa), was 
then recorded. The crosshead speed of the left moving platen was 
3.5 mm/s. The area under the tensile strength curve (AUCTS) 
obtained from the Leuenberger model was used to determine the 
compactibility of the materials [16]: 
σt = Tmax (1-exp (-γPρ) (2) 
Where, TS is the radial tensile strength (MPa), Tmax is the theoretical 
tensile strength at infinite compression pressure, γ is the 
compression susceptibility parameter (MPa−1), ρ is the relative 
density and P is the compression pressure (MPa). 
Dilution potential (DP) 
Gemfibrozil was used as a model drug for direct compression 
due to its poor compaction properties. Tablets of ∼700 mg in 
weight containing different levels of excipient (0, 5, 20, 50, 80, 
90, 95 and 100 %) and a poorly compressible drug (gemfibrozil), 
were prepared, and their tensile strength was determined. 
Gemfibrozil and the test excipient were mixed in a mortar and 
pestle for 5 min and then compressed on a single punch tablet 
press at 30, 90 and 120 MPa at a dwell time of 1 s. The DP was 
obtained from the area ratio vs composition plots as reported 
previously [17]. 
Lubricant sensitivity (LS) 
Lubricant sensitivity was assessed by mixing powders previously 
passed through a 250 µm sieve with magnesium stearate at a 99:1 
weight ratio using a V-blender (Rhiddi Pharma, India) for 5 min. 
Tablets were prepared using a single punch tablet press at a dwell 
time of 1 s at a pressure, so a compact with ~ 20 % porosity is 
obtained. The lubricant sensitivity was expressed as the lubricant 
sensitivity ratio as reported previously [18]. 
Reprocessing susceptibility 
Biconvex compacts of ~30 % porosity, each weighing about 300 mg 
and measuring 8.7 mm in diameter were made using an eight station 
tablet machine (Rhiddi Pharma, India). Compact hardness was 
measured and converted to tensile strength and tablet pieces were 
milled and passed through a 250 µm sieve, and subsequently 
compressed. Compacts were analyzed in a hardness tester, and data 
were transformed to tensile strength.  
Elastic recovery (ER) 
Compacts of ∼300 mg were made on a single punch tablet press 
equipped with a flat-faced 6.5 mm diameter tooling at 20 % porosity. 
Tablet thickness was measured immediately after ejected (0.01 mm 
sensitivity) and after 15 d of storage. The ER was calculated as 
reported previously [19]. 
Compact water uptake and compact disintegration tests 
Tablets, each weighing ~300 mg, were made on a single punch tablet 
press using a 6.5 mm round, flat-faced punches and die set at a dwell 
time of 1 s. Compression forces were controlled, so compacts of 30-
40 % porosity were obtained. Compacts were stored in a chamber 
containing distilled water at 25 °C for 15 d keeping a relative 
humidity of ~100 %. The increase of weight was measured with 
time and expressed as a percentage. On the other hand, compact 
disintegration was performed in 1000 mL of distilled water at 37 ºC 
employing an Erweka GmbH disintegration apparatus (39-133-115, 
Hanson Research Corporation, Northridge, CA, USA) at 30 strokes/ 
min. 
Dissolution studies 
A formulation mixture containing 600 mg of gemfibrozil, 25 mg 
of crospovidone, 32 mg of sodium lauryl sulfate, 17 mg of 
magnesium stearate and 142 mg of testing excipient was blended 
on a mortar and pestle. The dry mixtures were then compressed 
in a single station tablet press (Compac 060804, Indemec, 
Columbia) at ~75MPa to form cylindrical matrices. The release 
studies were conducted on an Erweka (DT6-K, Erweka GmbH, 
Milford, CT) Type 2 apparatus operated at 37 °C and 50 rpm for 
30 min. A 900 mL of pH 7.5 phosphate buffer was used as a 
release medium. Aliquots of 5 mL each, were taken, filtrated and 
diluted to 50 mL with 1N NaOH before measurement. The 
concentration of gemfibrozil was found by UV analysis (HACH 
DR500, HACXH Company, Loveland, CO) at 276 nm according to 
the USP 38 NF 38 specifications. 
Echeverri et al. 
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RESULTS AND DISCUSSION 
Powder properties 
The powder properties of the SOR: ACD composite and commercial 
excipients are shown in table 1, and the morphology features are 
shown in fig. 1. The agglomerate had 158 µm in size and was 
comparable to that of Ludipress®, Cellactose 80®and SOR. In 
contrast, ACD had the smallest particle size followed by Prosolv 
SMCC 90®. Further, the agglomerate, SOR, and Ludipress® had the 
lowest true density, whereas ACD and Prosolv SMCC 90®had the 
highest values. Commercial materials such as Prosolv SMCC 90®, 
Cellactose 80® and Ludipress® presented the lowest bulk (0.36, 0.40 
and 0.48 g/cc) and tap densities (0.5, 0.5 and 0.7 g/cc), whereas ACD 
and the agglomerate had the largest values (0.69, 0.51 g/cc, and 
1.03, 0.94 g/cc, respectively).  
Moreover, since SOR and the agglomerate presented a large density 
and regular shape, they also exhibited the smallest porosity (58.9 
and 50.6 %, respectively). This is beneficial to dilute small dose 
drugs. On the other hand, Prosolv SMCC 90® and Cellactose 80®had 
the largest porosity. Further, Ludipress®, the agglomerate, and SOR 
had the largest flow rate due to their more regular shape, smooth 
surface and high bulk density. Conversely, ACD showed the slowest 
flow rate. This is mainly attributed to its small particle size and 
irregular particle shape. 
 
  
Agglomerate Cellactose 80® 
  
Prosolv SMCC 90® Ludipress® 
  
ACD SOR 
Fig. 1: Optical microphotographs of the agglomerate and commercial excipients 
Echeverri et al. 
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Table 1: Powder properties commercial materials were retested for moisture content and results are shown in here 
Property Agglomerate Cellactose 80® Ludipress® Prosolv SMCC 90® ACDa SORb 
PSc (µm) 158±20.1 137±29 172±22.1 80±16 14.3±1.5 173±22 
Bulk density (g/cm3) 0.51±0.00 0.40±0.00 0.48±0.01 0.36±0.00 0.69±0.00 0.64±0.0 
Tapped density (g/cm3) 0.94±0.10 0.50±0.02 0.70±0.0 0.50±0.00 1.03±0.04 0.70±0.04 
True density (g/cm3) 1.52±0.00 1.57±0.00 1.52±0.00 1.61±0.00 2.99±0.00 1.55±0.00 
Porosity ( %) 50.6 75.8 65.1 78.9 76.9 58.7 
Moisture content ( %) 1.00 1.1 1.3 2.5 0.20 0.80 
Flow rate (g/s) 19.8±1.3 16.5±1.9 22.5±3.8 12.9±0.5 6.9±1.1 23.9±3.2 
Compressibility (MPa2) 13.3 20.0 22.0 25.0 39.0 15.0 
Anhydrous calcium diphosphate, b. sorbitol, c. particle size. Experiments were performed in triplicate. Data are given in mean±SD 
 
Tableting properties 
In order to assess the compressibility of materials, the Heckel 
analysis was employed, and the Heckel curves are shown in fig. 2. 
The yield pressure value, (Py), refers to the pressure at which the 
material begins to deform plastically. According to the Py values, the 
agglomerate showed a superior plastic nature even surpassing SOR 
which it is the classic plastic deforming material. In general, a low Py 
value is related to a high ductility of the material. In this case, the 
agglomerate (∼57.6 MPa) and SOR (72 MPa) had the lowest values; 
whereas, Ludipress® and ACD had the highest Py values (∼240 and 
383 MPa, respectively). Prosolv SMCC 90® and Cellactose 80® 
presented intermediate Py values (∼103 and 146 MPa, respectively). 
Thus, it is deduced that the agglomerate and SOR were the most 
plastic deforming materials upon compression while Ludipress® and 
ACD were the most brittle deforming materials. 
  
Table 2: Tableting properties 
Test Agglomerate Cellactose 80® Ludipress® Prosolv SMCC 90® ACDa SORb 
Pyc (MPa) 57.6 145.6 239.7 102.7 383.0 71.8 
True density (g/cm3) 1.52 1.57 1.53 1.11 2.99 1.55 
Dad 0.67 0.48 0.52 0.36 0.44 0.67 
Doe 0.39 0.26 0.32 0.23 0.17 0.31 
Dbf 0.29 0.22 0.20 0.14 0.27 0.35 
AUCHCg (MPa2) 862.4 424.8 360 449.6 260.2 768.4 
SRSh ( %) 30.2 22.4 58.9 1.1 14.3 49.6 
γci(MPa-1) 0.016 0.005 0.003 0.014 0.006 0.029 
Tmaxj(MPa) 4.1 4.6 2.3 5.5 1.7 4.9 
Compactibility (AUCTS)k (MPa2) 268.2 141.7 48.1 342.4 48.9 420.5 
Lubricant sensitivity 0.28 0.17 0.82 0.61 0.00 0.13 
Elastic recovery ( %) 1.0 0.01 0.02 0.0 0.0 3.0 
Dilution potencial ( %) 37 36 40 33 82 40 
Compact water uptake ( %) 14 1.0 1.1 2.4 1.1 35.7 
Compact disintegration (min) 6.6±0.6 6.3±1.5 1.5±0.6 >30 >30 8 
Gemfibrozil release ( %) 86±6 53±5.7 48±4.8 35±2.4 28±5.4 17±2.9 
 
Anhydrous calcium diphosphate, b. sorbitol, c. powder yield 
pressure, d. total compact densification, e. initial powder packing/ 
densification, f. total compact densification by particle 
rearrangement/fragmentation, g. the area under the curve from the 
Heckel model, h. strain rate sensitivity, i. compression susceptibility 
parameter j. theoretical tensile strength at infinite compression 
pressure, k. the area under the tensile strength curves obtained from 
the Leuenberger model. Experiments were performed in triplicate. 
data given in mean±SD. 
Based on the area under the Heckel curve (AUCHC) it is deduced that 
the agglomerate and ACD had the largest and lowest powder 
compressibility, respectively. Usually, plastic materials had a high 
densification, whereas those with a low Py were less compressible. 
Compressibility is directly obtained from the AUC of the Heckel 
curve and showed the agglomerate having the highest 
compressibility followed by SOR. On the contrary, ACD and 
Ludipress® showed the lowest compressibility. Therefore, the 
decreasing trend of plastic deformation upon consolidation followed 
the order: agglomerate>SOR>Prosolv SMCC 90®>Cellactose 80®> 
Ludipress®>ACD. 
The Do, Da and Db parameters, calculated from the Heckel plots, 
represent the initial packing of the material upon die filling, total 
packing at low pressures, and degree of powder bed arrangement 
due to fragmentation at low pressures, respectively. The 
agglomerate presented the largest densification by die filling, and 
along with SOR had the total largest densification (Da) and particle 
rearrangement in the powder bed at low initial compression 
pressures. On the contrary, Prosolv SMCC 90® and ACD presented 
the lowest densification driven by gravity forces. This finding is 
explained by the low particle size and high cohesiveness between 
particles. Further, the high densification, particle size and regular 
shape of SOR contributed to its high rearrangement behavior in the 
powder bed. Conversely, Prosolv SMCC 90® and Ludipress® 
presented the lowest rearrangement in the powder bed at initial 
compression pressures (Db∼0.14-0.20). This is attributed to 
morphological and surface factors. 
 
 
Fig. 2: Heckel curves of the agglomerate and commercial 
excipients. Experiments were performed in triplicate. Error 
bars corresponds to standard deviation 
Echeverri et al. 




The fitting parameters obtained from the Leuenberger model are 
shown in table 2 and tensile strength curves are shown in fig. 3 [20]. 
Prosolv SMCC 90® had the best compactibility, whereas ACD and 
Ludipress® showed the lowest values. The agglomerate formed 
compacts that were stronger than those made of Ludipress®, 
Cellactose 80® and ACD. The magnitude of difference in compact 
tensile strength increased with increasing pressures. This change 
was very small for ACD and Ludipress®. The compressibility 
parameter (γc) is inversely related to the powder yield pressure, and so 
does the Heckel slope. For instance, plastic deforming materials such as 
SOR, the agglomerate and Prosolv SMCC 90®presented the highest γc 
values of 0.029, 0.016 and 0.014 MPa-1, respectively. The area under the 
curve of tensile strength (AUCTS) was used to rank materials according 
to their compactibility. The trend followed the order: SOR>Prosolv SMCC 
90®>agglomerate>Cellactose 80®>ACD ≅ Ludipress®. 
 
 
Fig. 3: Compactibility of the agglomerate and commercial 
excipients, Experiments were performed in triplicate. Error 
bars corresponds to standard deviation 
 
The susceptibility to compression speed was evaluated by the strain 
rate sensitivity (SRS) and showed that plastic materials such as 
Ludipress® and SOR had the largest SRS (58.9 and 49.6 %, 
respectively). Conversely, ACD and Prosolv SMCC 90®had the least 
sensitivity to compaction speed. This indicates that dwell time did 
not play a major role on the amount of contact points by sliding of 
crystal planes and that a high plastic deforming character not always 
suggests a high compactibility. 
Ejection force 
Fig. 4 shows the ejection forces obtained for each excipient. The 
materials exhibiting the best performance were Prosolv SMCC 90®, 
SOR and agglomerate; whereas ACD, Ludipress® and Cellactose 80® 
produced compacts that required high ejection forces making them 
susceptible to capping and lamination. 
 
 
Fig. 4: Ejection force of the agglomerate and commercial 
materials, Experiments were performed in triplicate. Error bars 
corresponds to standard deviation 
 
Reworking susceptibility 
Fig. 5 shows the values of the tensile strength of tablets obtained 
before and after reprocessing. Usually, reprocessing could have a 
negative impact on the mechanical properties of plastic deforming 
materials whereas a brittle deformation might improve the tableting 
performance. In this case, the agglomerate was highly affected, 
whereas reprocessing improved the mechanical properties of less 
plastic deforming materials having a high specific surface area such 
as ACD and Prosolv SMCC 90®. The latter also contains a 2 % of 
fumed silica, which is known for having the high specific surface area 
of ~200 m2/g. The loss of compactibility of the agglomerate could be 
attributed to the way ACD is embedded in the agglomerate after 
reprocessing. Before reprocessing, the ACD is incorporated into the 
agglomerated granules, but after milling, the plastic properties of the 
SOR component prevailed and had a greater negative impact on 
tableting performance. Some studies suggested that the work of 
hardening which is generated after pre-compression might be the 
cause for the loss of compactibility [21]. The work hardening implies 
that after recompression a great amount of defects in the particles and 
entanglement of new dislocations occurs while being deformed 
plastically. These defects harden particles and make plastic 
deformation more difficult for a subsequent compaction process [22]. 
 
 
Fig. 5: Reworking susceptibility of the materials studied, 
Experiments were performed in triplicate 
 
Lubricant sensitivity 
The lubricant sensitivity is a good indicator of the excipient 
performance since lubricants form a mixed interface between the 
particles reducing their binding capacity for the compression 
process (9). This effect could be related to the amount of lubricant 
used, mixing time and the presence of excipients with plastic 
deformation characteristics [23, 24]. The lubricant sensitivity of the 
agglomerate and commercial excipients is shown in table 2. The 
lubricant sensitivity was tested with 1.0 % w/w magnesium 
stearate. The results depicted in table 2 showed that except for ACD 
most materials were susceptible to magnesium stearate. This means 
that magnesium stearate was efficient at coating the surface of 
particles and prevented the formation of hard compacts. This effect 
was more pronounced in materials that had a smooth surface such 
as Ludipress® and Prosolv SMCC90®. Thus, the lubricant coated the 
surface of the particles and thereby, restricted the contact points 
between particles rendering compacts of low strength and hence, 
caused a high lubricant sensitivity. For instance, the negative effect 
of lubricants on the tensile strength of ACD was negligible since the 
formation of new surfaces, free of lubricants was not prevented 
during compaction. Thus, the film lubricant coating on the ACD 
surface appears as uncompleted, due to its highly irregular particles 
having a high surface area in which the lubricant was trapped in the 
pores [18]. 
Elastic recovery (ER) and dilution potential (DP) 
The elastic recovery depends on the elasticity of the compressed 
material. It occurs due to the reduction in the bonding surface of the 
Echeverri et al. 
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particles which in turn, leads to the formation of weak compacts 
[14]. The elastic recovery is also related to the capping and 
lamination tendency of tablets [15]. The ER for all materials was 
small (<1 %) except for SOR (3 %) indicating that ER was 
independent of the deformation mechanism upon powder 
consolidation and hence, most materials had a low free energy 
stored upon compression and their particles behaved less elastically. 
It is possible that the high ER of SOR was due to its rubbery state at 
room temperature.  
On the other hand, the dilution potential is the minimum amount of 
excipient needed to be mixed with a drug to obtain a tablet with a 
suitable compactibility and friability. Thus, it defines the minimal 
proper drug and excipient ratio in a formulation [13]. In order to 
assess the effect of a poorly compressible substance on the 
compactibility of the agglomerate and other materials, compacts 
containing different weight ratios of the test material and 
gemfibrozil were prepared and their dilution potential (DP) 
determined. Results presented in table 2 suggest that except for 
ACD, most materials had a good DP (~33-40 %). Further, the level of 
these excipients did not exceed 80 %, so coherent compacts can be 
successfully produced. Therefore, these materials are recommended 
for direct compression of poorly compressible drugs due to their 
ability to form tablets by Van der Waal forces and hydrogen bonding. 
The lack of these bonding characteristics in a material might limit 
the mechanical interlocking and formation of contact points needed 
for consolidation and particle binding under pressure which is 
required to make strong compacts. The above results indicate that 
compactibility was related to DP since highly compactable materials 
such as Prosolv SMCC 90®, Cellactose 80®, agglomerate and SOR had 
better DP than Ludipress®and ACD. 
Compact disintegration 
The disintegration time of compacts is listed in table 2. As expected, 
materials having a very low compactibility such as Ludipress® and 
Cellactose 80® presented a fast disintegration. Further, highly water 
soluble materials such as SOR and agglomerate compacts took less 
than 8 min to disintegrate. On the contrary, the compact 
disintegration of Prosolv SMCC90® and ACD took more than 30 min 
due to the high compactibility and less hydrophilic character of 
these two materials, respectively. 
Dissolution studies 
A compact formulation containing 600 mg of gemfibrozil, 25 mg of 
crospovidone, 32 mg of sodium lauryl sulfate, 17 mg of magnesium 
stearate and 142 mg of testing excipient was made. The results listed 
in table 2 shows that except for the agglomerate, all materials failed 
to release at least 80 % of gemfibrozil within 30 min. This indicates 
that this new composite had better release properties than the 
parent SOR and ACD, especially when formulated by direct 
compression using poorly water soluble drugs such as gemfibrozil 
fulfilling the S2 criterion of the US Pharmacopoeia. 
CONCLUSION 
The new agglomerate had better compactibility and better 
gemfibrozil dilution potential than ACD and Cellactose 80®. On the 
contrary, Ludipress®and ACD were the least compactable materials. 
Further, the agglomerate along with SOR was the most compressible 
materials and had a faster disintegration time than Prosolv SMCC 
90® and ACD. The agglomerate was found to be less friable, less 
sensitive to magnesium stearate, and possessed better gemfibrozil 
loading capacity than ACD. Further, it was the only co-processed 
excipient that formed compacts by direct compression which 
successfully fulfilled the in-vitro dissolution of poorly water soluble 
drugs such as gemfibrozil. The above results clearly show that the 
new composite can be used as an excipient for the preparation of 
solid dosage forms having a poorly compressible drug such as 
gemfibrozil. 
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